2'-Deoxyadenosine-5'-monophosphate
| Code | Size | Price |
|---|
| TAR-T4737-50mg | 50mg | £95.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T4737-100mg | 100mg | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T4737-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Adenosine is a nucleoside comprised of adenine attached to a ribose (ribofuranose) moiety via a -N9-glycosidic bond. Deoxyadenosine monophosphate is a derivative of the common nucleic acid ATP, or adenosine triphosphate, in which the -OH (hydroxyl) group on the 2' carbon on the nucleotide's pentose has been removed (hence the deoxy- part of the name). Additionally, the monophosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis. Deoxyadenosine monophosphate is abbreviated dAMP.
CAS:
653-63-4
Formula:
C10H14N5O6P
Molecular Weight:
331.225
Pathway:
Metabolism;
Purity:
0.9983
SMILES:
Nc1ncnc2n(cnc12)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
Target:
Endogenous Metabolite
References
Zhong H, Zang KT.Therapeutic approaches for chronic gastralgia based on differentiation of symptoms and signs.Di Yi Jun Yi Da Xue Xue Bao. 2002 Jul;22(7):639-40.
Hohenester E , Hutchinson W L , Pepys M B , et al. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP[J]. Journal of Molecular Biology, 1997, 269(4):0-578.
Xiao-Rong C , Gui-Ming L I , Jiang-Rong W , et al. Portal hemodynamics in patients with different syndromes of cirrhosis[J]. Journal of Chinese Integrative Medicine, 2004, 2(3):178.
Duarte V , Muller J G , Burrows C J . Insertion of dGMP and dAMP during in vitro DNA synthesis opposite an oxidized form of 7,8-dihydro-8-oxoguanine.[J]. Nucleic Acids Research, 1999, 27(2):496-502.
Avkin S , Adar S , Blander G , et al. Quantitative measurement of translesion replication in human cells: Evidence for bypass of abasic sites by a replicative DNA polymerase[J]. Proceedings of the National Academy of Sciences, 2002, 99(6):3764-3769.